Samsara Vision Europe

Samsara Vision Europe

Medical Device

Far Hills, New Jersey 1,342 followers

Bringing vision and freedom back to late-stage AMD patients.

About us

Samsara Vision's SING IMT is bringing vision and freedom back to late-stage AMD patients. Samsara Vision is a speciality medical device company engaged in the Research & Development, manufacturing, and marketing of proprietary implantable ophthalmic devices that are intended to significantly improve vision and quality of life for individuals with untreatable retinal disorders. Samsara Vision’s SING IMT is a CE-marked Galilean telescope implant designed to improve visual acuity and quality of life for patients with late-stage age-related macular degeneration (AMD). The design improves upon a 1st-generation miniature telescope device implanted in more than 600 patients living with late-stage AMD. SING IMT features the same ultra-precision wide-angle micro-optics optic as its predecessor with an improved haptic design to create a telephoto effect. Images are magnified 2,7x and projected onto healthy photoreceptors surrounding the macula in the back of the eye, reducing the impact of the AMD “blind spot” in central vision and allowing patients to see images that may have been unrecognizable before. Our goal is to help patients reconnect to the things in life they love to see and do. To help achieve this, we will establish a high level of collaboration with our healthcare provider customers through a broad range of direct support programs and services. Disclaimer: The SING IMT is not FDA approved. Chief Commercial Officer Jason Herod Email: singimt@samsaravision.com

Industry
Medical Device
Company size
11-50 employees
Headquarters
Far Hills, New Jersey
Specialties
medical device, ophthalmic technology, and healthcare

Updates

Affiliated pages

Similar pages